Date published: 2026-2-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

EF-1β Inhibitors

The chemical class of "EF-1β Inhibitors" encompasses a range of compounds, each with the potential to influence cellular mechanisms or pathways that might indirectly affect the activity or expression of the EF-1β protein. EF-1β, encoded by the EF-1β gene, is involved in protein synthesis and regulation, although the full extent of its functions and interactions within the cell are not completely understood. The inhibitors and activators listed do not interact directly with EF-1β but are thought to target different signaling pathways and cellular processes that might modulate its function or expression.

Compounds such as Cycloheximide and Rapamycin, which inhibit protein synthesis and the mTOR pathway respectively, might influence the protein synthesis machinery and degradation pathways, potentially affecting EF-1β activity. Staurosporine, a broad-spectrum kinase inhibitor, and LY294002, a PI3K inhibitor, can modulate cell signaling pathways that may intersect with those involving EF-1β.

MEK inhibitors like PD98059, histone deacetylase inhibitors such as Trichostatin A, and DNA methyltransferase inhibitors like 5-Azacytidine can alter gene expression and epigenetic patterns, potentially impacting the regulation of genes related to EF-1β. Forskolin, by increasing cAMP levels, and Y-27632, a Rho kinase inhibitor, could modulate various cellular responses and pathways, potentially influencing EF-1β.

Bortezomib, a proteasome inhibitor, and Curcumin, known for its broad effects on cellular signaling, can influence protein stability and multiple signaling pathways, respectively, potentially including those involving EF-1β. SB431542, a TGF-beta receptor inhibitor, targets specific cellular processes and pathways that might have implications for the function or regulation of EF-1β.

This class of inhibitors and activators is characterized by its indirect mode of action, targeting various signaling cascades and cellular processes to influence the activity or expression of EF-1β. Each compound has distinct pharmacological properties and modes of action, reflecting the complexity of cellular signaling networks and the multifaceted nature of protein regulation within these networks. The diversity in this chemical class underscores the broad spectrum of molecular interactions and pathways that can be modulated to affect a specific protein's activity, such as EF-1β, in complex biological systems.

SEE ALSO...

Items 1 to 10 of 19 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits protein synthesis, potentially affecting the expression of proteins interacting with EF-1β.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, could influence protein synthesis and degradation pathways related to EF-1β.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$52.00
$125.00
$182.00
11
(1)

Blocks the elongation phase of protein synthesis, which could indirectly reduce the functional demand on EEF1B2.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Kinase inhibitor, might affect multiple signaling pathways related to EF-1β.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, might impact cell survival and growth pathways involving EF-1β.

Tetracycline

60-54-8sc-205858
sc-205858A
sc-205858B
sc-205858C
sc-205858D
10 g
25 g
100 g
500 g
1 kg
$63.00
$94.00
$270.00
$417.00
$634.00
6
(1)

Binds to the 30S subunit of the ribosome, inhibiting the binding of aminoacyl-tRNA and potentially reducing the role of EEF1B2 in translation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, potentially altering MAPK/ERK signaling pathways involving EF-1β.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Inhibits peptide bond formation by binding to 60S ribosomal subunits, which may indirectly affect EEF1B2′s role in translation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor, may alter gene expression potentially impacting EF-1β.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA, potentially diminishing the need for EEF1B2 activity.